IDEXX LABORATORIES INC /DE Cost of Revenue 2008-2026 | IDXX
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is IDEXX LABORATORIES INC /DE's current cost of revenue?
IDEXX LABORATORIES INC /DE (IDXX) annual cost of revenue for 2025 was $1.64B, a 8.27% increase from 2024. IDEXX LABORATORIES INC /DE cost of revenue for the quarter ending March 31, 2026 was $418.1M.
What was IDEXX LABORATORIES INC /DE's cost of revenue in 2024?
IDEXX LABORATORIES INC /DE annual cost of revenue for 2024 was $1.52B, a 3.24% increase from 2023.
What was IDEXX LABORATORIES INC /DE's cost of revenue in 2023?
IDEXX LABORATORIES INC /DE annual cost of revenue for 2023 was $1.47B, a 7.92% increase from 2022.
What is IDEXX LABORATORIES INC /DE's 5-year cost of revenue CAGR?
IDEXX LABORATORIES INC /DE cost of revenue grew at a compound annual growth rate (CAGR) of 7.68% from FY2020 to FY2025, going from $1.14B to $1.64B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+7.7%
FY2020
$1.14B
→
FY2025
$1.64B
080910111213141516171819202122232425
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.64B | +8.3% | 10-K |
| FY2024 | $1.52B | +3.2% | 10-K |
| FY2023 | $1.47B | +7.9% | 10-K |
| FY2022 | $1.36B | +2.8% | 10-K |
| FY2021 | $1.33B | +16.8% | 10-K |
| FY2020 | $1.14B | +9.1% | 10-K |
| FY2019 | $1.04B | +7.2% | 10-K |
| FY2018 | $971.7M | +11.5% | 10-K |
| FY2017 | $871.7M | +9.0% | 10-K |
| FY2016 | $800.0M | +12.4% | 10-K |
| FY2015 | $711.6M | +6.3% | 10-K |
| FY2014 | $669.7M | +7.9% | 10-K |
| FY2013 | $620.9M | +4.5% | 10-K |
| FY2012 | $594.2M | +3.8% | 10-K |
| FY2011 | $572.2M | +9.0% | 10-K |
| FY2010 | $524.8M | +3.8% | 10-K |
| FY2009 | $505.4M | +2.2% | 10-K |
| FY2008 | $494.3M | - | 10-K |
Company: IDEXX LABORATORIES INC /DETicker: IDXXSector: OtherIndustry: In Vitro & In Vivo Diagnostic SubstancesView company profile →